| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 02/06/2008 | CN101119987A Novel compounds |
| 02/06/2008 | CN101119986A Optically active tetrahydronaphthalene derivative |
| 02/06/2008 | CN101119971A Cyclohepta[b]pyridine-3-carbonylguanidine derivative and pharmaceutical product containing same |
| 02/06/2008 | CN101119747A Tissue factor production inhibitor |
| 02/06/2008 | CN101119718A Pharmaceutical compositions comprising NEP-inhibitors, inhibitors of the endogenous endothelin producing system and diuretics |
| 02/06/2008 | CN101117642A Polypeptide capable of lowering blood pressure and method for preparing same |
| 02/06/2008 | CN101116737A Method for preparing traditional Chinese medicine for treating coronary disease |
| 02/06/2008 | CN101116722A Pharmaceutical formulations with the raw material containing panax, ophiopogon root and schisandra fruit, processes for their preparation, the raw material and the quality control method for the prepa |
| 02/06/2008 | CN101116712A Drug for curing cerebral infarction --- liquid for promoting blood circulation and removing blood stasis |
| 02/06/2008 | CN101116694A Chinese traditional medicine for treating angitis, method for preparing the same and uses thereof |
| 02/06/2008 | CN101116689A Oral Chinese traditional medicine composition for treating hypertension |
| 02/06/2008 | CN101116686A Medicine for treating fatness and its complication |
| 02/06/2008 | CN101116685A Hypertension-treating medicine |
| 02/06/2008 | CN101116684A Mongolian medicine for treating cerebrovascular disease |
| 02/06/2008 | CN101116661A Application of 5-hydroxymethyl furfural in the preparation of medicine for protecting vascellum endothelial cell |
| 02/06/2008 | CN101116660A Use of compound for resisting atherosis thrombosis in the obtaining of medicine for treating vascellum disease |
| 02/06/2008 | CN101116659A Eplerenone soft capsule preparations and method for preparing the same |
| 02/06/2008 | CN101116658A Eplerenone liquid capsule preparations and method for preparing the same |
| 02/06/2008 | CN101116507A Ginseng wheat conjee for pacifying the mind |
| 02/06/2008 | CN100366740C Cloning, Expression and bioactivity of new actinion toxin |
| 02/06/2008 | CN100366629C Technique for preparing pharmaceutical product of í«Denghuayisuí» in high purity |
| 02/06/2008 | CN100366628C Effective parts of fructus sophorae flavone production and use thereof |
| 02/06/2008 | CN100366614C 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity |
| 02/06/2008 | CN100366606C New phenylamidine derivatives process for preparing the same and their use as medicaments |
| 02/06/2008 | CN100366605C Compounds to treat alzheimer's disease |
| 02/06/2008 | CN100366277C Medicine composition for treating cardiac and cerebral vascular diseases and its prepn |
| 02/06/2008 | CN100366270C Medicine for curing cardiovascular and cerebrovascular diseases |
| 02/06/2008 | CN100366259C Application of general saponin of gen-seng fruit in the preparation process of myocarditis treating medicine |
| 02/06/2008 | CN100366257C Stromal cell-derived factor-1 mediates stem cell homing and tissue regeneration in ischemic cardiomyopathy |
| 02/06/2008 | CN100366254C Use of vasopeptidase inhibitors in the treatment of metabolic diseases, nephropathy and advanced glycation end-product associated diseases |
| 02/06/2008 | CN100366252C N-aryl piperidine substituted biphenylcarboxamides as inhibitors of apolipoprotein B secretion |
| 02/06/2008 | CN100366250C Freeze dried vinpocetine powder injection and its preparation process |
| 02/06/2008 | CN100366247C Single nitrate isosorbide delayed-release tablets |
| 02/05/2008 | US7326812 Arylsulfonamidobenzylic compounds |
| 02/05/2008 | US7326801 2-amino-propanol derivatives |
| 02/05/2008 | US7326794 Process for the preparation of high purity perindopril and intermediates useful in the synthesis |
| 02/05/2008 | US7326789 E.g., 2-(4-Chloro-phenylsufonylamino)-4,5-dimethoxy-N-(4-(thiomorpholine-4-sulfonyl)-phenyl)-benzamide; cardiovascular disorders; hypotensive agents; angina pectoris, cardiac insufficiency, thrombolytic agents; atherosclerosis; activating soluble guanylate cyclase to adjust a disturbed cyclic GMP balance |
| 02/05/2008 | US7326785 Preparation of 3-(thienylalkenylenesulfonylamino)-1-(4--morpholinylcarbonyl-alpha-substituted methyl)pyrrolidone derivatives: 2-(5-Chlorothien-2-yl)-N-methyl-N-{(3S)-1-[(1S)-1-methyl-2-morpholin-4-yl-2-oxoethyl]-2-oxopyrrolidin-3-yl}ethenesulfonamide |
| 02/05/2008 | US7326730 Aminoadamantane derivatives as therapeutic agents |
| 02/05/2008 | US7326727 Furanthiazole derivatives as heparanase inhibitors |
| 02/05/2008 | US7326723 Autoimmune disease; antiinflammatory agents |
| 02/05/2008 | US7326720 Phenyl- and pyridylpiperidines with TNF activity |
| 02/05/2008 | US7326715 4-Phenyl-6-substituted-pyrimidine-2-carbonitrile derivatives |
| 02/05/2008 | US7326714 6,7-Dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines |
| 02/05/2008 | US7326707 Bicyclic melanocortin-specific compounds |
| 02/05/2008 | US7326705 2-amino or carbonylamino-4-carbocyclic imidazoles and thiazoles; antiischemic agents, hypotensive agents, antiarrhythmia agents; can be coadministered with other drugs |
| 02/05/2008 | US7326696 Amino-methyl substituted tetracycline compounds |
| 02/05/2008 | US7326693 Antisense modulation of c-reactive protein expression |
| 02/05/2008 | US7326685 Diagnostic or therapeutic somatostatin or bombesin analog conjugates and uses thereof |
| 02/05/2008 | US7326682 Conotoxin peptides |
| 02/05/2008 | US7326678 Obesity-related disease or disorder, hyperlipidemias, atherosclerosis, diabetes, and hypertension |
| 02/05/2008 | US7326425 Biologically active compound hydrogen bonded to a first polyester containing tyrosine-derived diphenol units blended with a second polymer that degrades to promote the release of the active compound |
| 02/05/2008 | US7326411 Use of amino-terminally truncated RANTES to inhibit HIV viral replication |
| 02/05/2008 | US7326174 Cardiac disease treatment and device |
| 02/05/2008 | US7325355 Methods for treatment of atherosclerosis using 1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)-4-aminoisoindoline |
| 02/05/2008 | CA2417635C Heterocyclic compounds useful as inhibitors of tyrosine kinases |
| 02/05/2008 | CA2402686C Vitronectin receptor antagonist bicyclic compounds, preparation method and compositions containing same |
| 02/05/2008 | CA2349227C Substituted 2-phenylbenzimidazoles, the production thereof and their use |
| 02/05/2008 | CA2313618C Transmucosal formulations of levosimendan |
| 02/05/2008 | CA2302276C Methods of treating capsules and dry, powdered pharmaceutical formulations |
| 02/05/2008 | CA2264065C Acylaminoalkenylene-amide derivatives as nk1 and nk2 antagonists |
| 02/05/2008 | CA2187161C Dna encoding precursor of interleukin-1.beta. converting enzyme-related cysteine proteinase ii (icerel-ii) |
| 02/05/2008 | CA2166155C Agents binding to hyaluronic acid binding domains and the use thereof |
| 01/31/2008 | WO2008014286A1 Vinyl phosphonate lysophosphatidic acid receptor antagonists |
| 01/31/2008 | WO2008013799A2 Treatment and prevention of cardiovascular disease using mast cell stabilizers |
| 01/31/2008 | WO2008013743A2 Methods for inhibiting reperfusion injury |
| 01/31/2008 | WO2008013324A1 Use of diabetes-related, liver-derived secreted protein in diagnosis or treatment of type-2 diabetes or vascular disorder |
| 01/31/2008 | WO2008012394A1 Sclerosing microfoam with co2, preparation device and uses thereof |
| 01/31/2008 | WO2008012372A1 Process for the preparation of candesartan cilexetil form i |
| 01/31/2008 | WO2008012371A1 Process for the preparation of amorphous and crystalline forms of candesartan cilexetil using column chromatography |
| 01/31/2008 | WO2008012346A1 Extended release pharmaceutical formulation of metoprolol and process for its preparation |
| 01/31/2008 | WO2007139833A3 Imidazoazephinone compounds |
| 01/31/2008 | WO2007137864A9 Use of inhibitors of pp2c for treating or preventing arteriosclerosis |
| 01/31/2008 | US20080027229 Compounds for the treatment of metabolic disorders |
| 01/31/2008 | US20080027228 Substituted thioacetamides |
| 01/31/2008 | US20080027134 Hydroxybiphenyl carboxylic acids and derivatives, method for producing the same and their use |
| 01/31/2008 | US20080027126 Pyrrolidin-2-One Derivatives for Use as Dp1 Receptor Agonists |
| 01/31/2008 | US20080027123 Reduction of levels of tumor necrosis factor-alpha and/or inhibition of phosphodiesterase 4; treating erythema nodosum leprosum in leprosy, rhematoid spondylitis, hepatitis or congestive heart failure |
| 01/31/2008 | US20080027121 Novel pyrone-indole derivatives and process for their preparation |
| 01/31/2008 | US20080027111 Treatment and prevention of cardiovascular disease using mast cell stabilizers |
| 01/31/2008 | US20080027109 bis-[2-(pivaloylamino)phenyl]disulfide; cholesteryl ester transfer protein (CETP); atherosclerosis, hyperlipidemia |
| 01/31/2008 | US20080027100 Functionally selective alpha2C adrenoreceptor agonists |
| 01/31/2008 | US20080027098 Derivatives of alpha-phenylthiocarboxylic and alpha-phenyloxy-carboxylic acids useful for the treatment of diseases responding to PPARalpha activation |
| 01/31/2008 | US20080027090 N-5,6,9,10,11,12-hexahydro-4H,8H-cyclohepta[4,5]pyrrolo[3,2,1-ij]quinolin-2-yl-3,3-dimethylbutanamide; for treating cardiovascular disorders, nervous system disorders e.g epilepsy, episodic ataxia type 1, paroxysmal dyskinesia, neurodegenerative spincerebrallar ataxia, Parkinson's disease |
| 01/31/2008 | US20080027084 antiinflammatory agent, anticarcinogenic agent; for treating inflammatory diseases, allergic, autoimmune, metabolic, cancer, cardiovascular diseases |
| 01/31/2008 | US20080027083 Modulators of chemokine receptor activity crystalline forms and process |
| 01/31/2008 | US20080027080 Cyclic derivatives as modulators of chemokine receptor activity |
| 01/31/2008 | US20080027078 9-[2-(1H-indol-3-yl)ethyl]-2-pyridin-4-yl-6,7,8,9-tetrahydro-4H-pyrimido[1,2-a]pyrimidin-4-one; glycogen synthase kinase 3 beta inhibitors; nerve growth factors; neurodegenerative diseases; Alzheimer's disease; Parkinson's disease; tauopathies; stroke; vision defects;antidiabetic agent; anticarcinogenic |
| 01/31/2008 | US20080027077 Novel biaromatic compounds that modulate PPARgamma type receptors and cosmetic/pharmaceutical compositions comprised thereof |
| 01/31/2008 | US20080027071 2-{2-[4-(2,3-Dihydrobenzo[1,4]dioxin-5-yl)piperazin-1-yl]ethylsulfanyl}-6-methylnicotinonitrile; serotonin and dopamine receptor antagonist, serotonin reuptake inhibitor; anxiolytic agent, antidepressant; panic and obsessive compulsive disorder, social phobia, eating disorders, psychosis |
| 01/31/2008 | US20080027070 2-amino--5-substituted pyrimidine inhibitors |
| 01/31/2008 | US20080027069 Quinazoline compounds |
| 01/31/2008 | US20080027062 2-amino-4-N-cyclohexylmethylamino-6-(L-erythro-1,2-dihydroxypropyl)-7,8-dihydro-pteridine; treatment of pathological blood pressure decreases, such as occur in septic or hemorrhagic shock, in tumor or cancer therapy with cytokines, liver cirrhosis; ulcerative colitis; NO synthase inhibitor |
| 01/31/2008 | US20080027049 Benzofurans as potassium ion channel modulators |
| 01/31/2008 | US20080027037 Cyclic compounds |
| 01/31/2008 | US20080027032 Combinations comprising cox-2 inhibitors and aspirin |
| 01/31/2008 | US20080027029 Cold menthol receptor-1 antagonists |
| 01/31/2008 | US20080027021 Use of cpg oligodeoxynucleotides to induce angiogenesis |
| 01/31/2008 | US20080026998 Human kunitz-type inhibitor with enhanced antifibrinolytic activity |
| 01/31/2008 | US20080026076 Quercetin supplementation to treat hypertension |